Last updated on July 2019

An Immunotherapy Study of Nivolumab Plus Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer


Brief description of study

The purpose of this study is to test the effectiveness and safety of nivolumab combined with ipilimumab compared to nivolumab monotherapy in participants with previously untreated kidney cancer that has spread.

Clinical Study Identifier: NCT03873402

Find a site near you

Start Over

Local Institution

Stamford, CT United States
  Connect »

Local Institution

Washington, WA United States
  Connect »

Local Institution

Orlando, FL United States
  Connect »

Local Institution

Chicago, IL United States
  Connect »

Local Institution

Boston, MA United States
  Connect »

Local Institution

Hackensack, NJ United States
  Connect »

Local Institution

Buffalo, NY United States
  Connect »

Local Institution

Lake Success, NY United States
  Connect »

Local Institution

West Reading, PA United States
  Connect »

Local Institution

Charleston, SC United States
  Connect »

Local Institution

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Local Institution

Mar del Plata, Argentina
  Connect »

Local Institution

Buenos Aires, Argentina
  Connect »

Local Institution

San Juan, Argentina
  Connect »

Local Institution

Santiago de Chile, Chile
  Connect »

Local Institution

Independencia, Chile
  Connect »

Local Institution

Vina del Mar, Chile
  Connect »

Local Institution

Besancon Cedex, France
  Connect »

Local Institution

Saint Herblain, France
  Connect »

Local Institution

Toulouse Cedex 9, France
  Connect »

Local Institution

Ciudad de Mexico, Mexico
  Connect »

Local Institution

Biala Podlaska, Poland
  Connect »

Local Institution

Saint-Petersburg, Russian Federation
  Connect »

Local Institution

Santiago Compostela, Spain
  Connect »

Local Institution

Rio Cuarto, Argentina
  Connect »

Local Institution

Angers Cedex 10, France
  Connect »

Local Institution

Marseille Cedex 9, France
  Connect »

Local Institution

Cluj-Napoca, Romania
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.